Arkolith/Insider Trading/URGN/Form 4

Barrett Elizabeth A.

Chief Executive OfficerUroGen Pharma Ltd. (URGN) · full profile →Form 4 · filed Feb 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2026Grant(A)153K—$0153K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-004638) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML